J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Board Meeting held on 26-May-2022 to consider financial statements for the period ended March 2022

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Investors/Analysts Meet with management

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 26, 2022, inter alia, to consider and approve {i) audited financial statements/annual financial results for the financial year ended on March 31, 2022; and {ii) recommendation of final dividend, if any, for financial year 2021-22.

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Issue of duplicate share certificate.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about issue of duplicate share certificate.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Closure of trading window

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about resignation of Ms. Ananya Tripathi as Non Executive - Non Independent Director of the company w.e.f. 11-Mar-2022

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript and Link of Recording

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Interim Dividend is 24-Feb-2022.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 14, 2022, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on February 14, 2022, declared Interim Dividend of 8.50 per equity share.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 14, 2022.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investors/analysts call with management

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about update on Acquisition of Brands and Related Assets from Sanzyme Private Limited

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript and Link of Recording of Investor/Analyst call

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 26, 2022

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Acquisition of a portfolio of brands, for use and commercialization within India, from Sanzyme Private Limited

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 29, 2021, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Audio recording of Earnings Conference call

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Audio recording of Earnings conference call

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Earnings conference call Transcript

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper cutting of extract of consolidated financial results for quarter ended on September 30, 2021

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 11, 2021, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 11, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Approval for re-classification of status from promoter/promoter group to public'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Revised contact details of Key Managerial Personnel'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Grant of 206463 Options.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Lakshay Kataria as Chief Financial Officer of the company w.e.f. October 04, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Submission of application to the Stock Exchanges for re-classification of status from promoter/ promoter group to public'.

JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 09, 2021. Further, the company has informed the Exchange regarding voting results.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Appointment of Statutory Auditor'.